GÖRG provided comprehensive legal advice to Munich-based start-up Twogee Biotech in connection with a seed financing round. In the round led by High-Tech Gründerfonds (HTGF) and Bayern Kapital, the company secured an investment volume of around €2.2 million. Additional supporters include AgriFoodTech Venture Alliance and the HEINZ Group.

Twogee Biotech is a biotechnology company founded in 2024 and based in Martinsried, near Munich. Based on its innovative platform, the company develops customized enzyme and strain solutions for the industrial conversion of biogenic side streams and residues into sustainable second-generation raw materials. Twogee Biotech enables the efficient utilization of biomass side streams and the chemical industry's transition to circular, low-carbon value creation. The start-up already has its first minimum viable products (MVPs) and has implemented pilot projects with industry partners. Its own laboratories and bioreactors are in operation.

With the new financial resources, Twogee Biotech plans to accelerate its market entry, commercially scale its platform, and establish a licensing-based business model.

A GÖRG team led by Munich-based partner Sebastian Frech provided legal support throughout the financing round.

Advisors Twogee Biotech GmbH

GÖRG Partnerschaft von Rechtsanwälten mbB 
Sebastian Frech (Lead, Partner, Venture Capital / M&A, Munich)
Dr Julian Stassek (Associated Partner, Labour and Employment Law, Munich)
Max Zeisler (Senior Associate, Venture Capital / M&A, Munich)
Judith Burggraf (Associate, Venture Capital / M&A, Munich)